Pulmonary functions in systemic sclerosis

A. Khoury, F. Abou-Trabeh, S. Hamdoun (Aleppo, Syrian Arab Republic)

Source: Annual Congress 2012 - Diffuse parenchymal lung disease III
Session: Diffuse parenchymal lung disease III
Session type: Thematic Poster Session
Number: 3665
Disease area: Interstitial lung diseases, Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Khoury, F. Abou-Trabeh, S. Hamdoun (Aleppo, Syrian Arab Republic). Pulmonary functions in systemic sclerosis. Eur Respir J 2012; 40: Suppl. 56, 3665

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary involvement in systemic sclerosis
Source: Eur Respir Monogr 2019; 86: 90-105
Year: 2019


Pulmonary function in progressive systemic sclerosis
Source: Eur Respir J 2002; 20: Suppl. 38, 62s
Year: 2002

Lung function and pulmonary hypertension in systemic sclerosis
Source: Eur Respir J 2006; 28: Suppl. 50, 548s
Year: 2006

Pulmonary hypertension in systemic sclerosis: different phenotypes
Source: Eur Respir Rev, 26 (145) 170056; 10.1183/16000617.0056-2017
Year: 2017



Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease
Source: Eur Respir Rev, 27 (148) 170102; 10.1183/16000617.0102-2017
Year: 2018



Pulmonary involvement and exercise limitation in patients with systemic sclerosis
Source: Eur Respir J 2004; 24: Suppl. 48, 53s
Year: 2004

Pulmonary arterial hypertension in systemic sclerosis: a distinctive endotheliopathy?
Source: Eur Respir J 2010; 35: 223-224
Year: 2010


Screening for pulmonary arterial hypertension in systemic sclerosis
Source: Eur Respir Rev 2009; 18: 162-169
Year: 2009



Metabolic profiling of pulmonary vascular phenotypes in systemic sclerosis
Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Year: 2020


Significance of pulmonary involvement in systemic sclerosis (SSc)– data from the German SSc-network
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Year: 2018



Clinical and laboratory features of systemic sclerosis with pulmonary involvement
Source: Eur Respir J 2001; 18: Suppl. 33, 512s
Year: 2001

Pulmonary hypertension in systemic scleroderma
Source: Eur Respir J 2003; 22: Suppl. 45, 269s
Year: 2003

Pulmonary manifestations of systemic sclerosis, a report from Iran
Source: Annual Congress 2011 - Rare diffuse lung diseases
Year: 2011


Fluid challenge test and pulmonary haemodynamics in patients with systemic sclerosis
Source: International Congress 2017 – PAH and CTEPH
Year: 2017

Response to PAH specific therapy in systemic sclerosis patients with extensive parenchymal changes and pulmonary hypertension
Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Year: 2020


Gas transfer measurement in systemic sclerosis associated pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Year: 2016

Vasodilator testing in pulmonary arterial hypertension associated with systemic sclerosis
Source: Eur Respir J 2006; 28: Suppl. 50, 548s
Year: 2006

Pulmonary hypertension in systemic sclerosis and systemic lupus erythematosus
Source: Eur Respir Rev 2011; 20: 277-286
Year: 2011



The genetics of systemic sclerosis
Source: Research Seminar 2008 - The Pulmonary Circulation: Scleroderma-Related Pulmonary Arterial Hypertension
Year: 2008